The drug "Ketanov" (pills) is included in the groupNSAIDs (non-steroidal anti-inflammatory drugs). The medication has a pronounced analgesic, anti-inflammatory and, to a moderate degree, antipyretic effect. The medicine "Ketanov", whose analgesic effect is comparable to that of morphine, is significantly superior in performance to other NSAIDs. After oral administration and intramuscular injection analgesic effect occurs in an hour and half an hour, the maximum effectiveness of the drug is noted after 2-3 and 1-2 hours, respectively.
The drug "Ketanov" (tablets) is absorbed quickly enough. The active substance (ketorolac) is able to penetrate into breast milk.
The medicine "Ketanov". Indications for use
The drug is prescribed for pain syndromemoderate and strong severity. To this state include: toothache, trauma, pain in the postoperative and postpartum period, myalgia, oncological diseases, arthralgia, radiculitis, neuralgia, sprains, dislocations, rheumatic diseases.
No medication is prescribed for increasedsensitivity, a combination of polyposis of the nose and sinuses (paranasal) of a recurrent nature, bronchial asthma, intolerance to drugs from the pyrazolone series and acetylsalicylic acid. Contraindicated drug "Ketanov" (pills) with lesions (erosive and ulcerative) in the digestive tract, hypovolemia (regardless of the cause), hypocoagulation, severe renal failure, bleeding or a high probability of their occurrence. The drug is not prescribed for liver failure, patients under sixteen, during pregnancy, lactation.
Medication "Ketanov" (pills) with cautionis prescribed with increased sensitivity to other NSAIDs, the presence of factors that increase gastrointestinal toxicity (smoking, alcoholism, cholecystitis), bronchial asthma, edematous syndrome. Under mandatory supervision of a specialist, the drug should be administered to patients over 65 years of age, pregnant.
Oral (inward) use of medication to individualsfrom sixteen to sixty-four years with a body weight of more than 50 kg recommended in the first reception of 20 mg, then four times a day for 10 mg. Patients whose body weight is less than 50 kg, or if there is renal failure, 10 mg is recommended in the first dose, then 10 mg four times a day. The amount for oral use should not exceed 40 mg / day.
Side effects are manifested in the form of gastralgia,stomatitis, diarrhea, vomiting, constipation, appetite disorders and other disorders of the gastrointestinal tract. Negative reaction in some cases is expressed in hematuria, low back pain, rapid urination, edematous renal origin. Rarely, ringing in the ears, hearing and vision disorders, rhinitis, puffiness of the larynx and lungs, bronchospasm can be noted. Adverse reactions (frequent) are headaches, drowsiness, dizziness, in rare cases, there is psychosis, depression, fever, fainting. In some cases, skin rash, hives, exfoliative dermatitis, exudative erythema (malignant), heaviness in the chest, itching of the skin, increased sweating may develop.
When an overdose of a single application of the effects manifested in the form of nausea, vomiting, impaired renal function, abdominal pain. Treatment in such cases is symptomatic.
When used in conjunction with paracetamolthe nephrotoxicity of ketorolac increases. With the simultaneous administration of other NSAIDs, corticotropin, ethanol, the risk of mucosal expression in the gastrointestinal tract and the occurrence of bleeding (gastrointestinal) increase.
With caution, the drug is used by persons whose activities are directly related to mechanisms or require high concentration of attention.
